Latest Blogs

Aug 15, 2019
Dr. Gil Morgan joins me in a conversation about how our perspectives have been enriched by work, parenthood, and online connections.
Aug 12, 2019
Over 400 attendees and exceptional international faculty members made the 2019 Best of ASCO Lebanon meeting a great success.
Aug 12, 2019
After a breast cancer diagnosis, cancer researcher Dr. Priscila Gonçalves went from "helper" to "helped." She discovered incredible kindness along the way.  
Aug 09, 2019
Planning for our first global meeting, ASCO Breakthrough: A Global Summit for Oncology Innovators, is almost complete.
Subscribe to this column

L. Michael Glode, MD, FACP, FASCO

L. Michael Glodé, MD, FACP, FASCO, is a Professor Emeritus at the University of Colorado Cancer Center. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.

May 26, 2015
This year, I plan to follow the ASCO Annual Meeting from the comfort of my home. It will be the first year of “missing” the Annual Meeting, and one question is whether I will have the discipline to watch enough presentations to feel like I have been sufficiently updated.
Apr 30, 2015
For the past month or so, one patient after another has come in with the question, “So, what do you think about 4-MU?” or “Did you hear about poliovirus killing cancer?” Actually, I have heard next to nothing about either, but of course I was intrigued as to where my patients get their information.
Apr 07, 2015
It has long been held that testosterone is the root of all evil—probably true for most wars, and possibly true for the development of prostate cancer....
Mar 05, 2015
I recently attended the co-sponsored Genitourinary Cancers Symposium. As usual, it was somewhat of a “firehose to take a drink” scenario with great presentations, more posters than you could possibly absorb, and lots of progress on many fronts.
Feb 03, 2015
In the past decade, a number of labs and companies have developed techniques to further define how a patient with prostate cancer, or suspected cancer, is likely to do. There are at least a dozen tests that are in various stages of commercialization, and it would be difficult to do justice to all...
Jan 07, 2015
It is always humbling to see how much you can miss in trying to keep up with medicine's developments, even in an incredibly narrow area like prostate cancer. Fortunately, there are many crutches like Medscape that offer help (along with targeted ads of course).

Pages